1. Home
  2. KTCC vs SCLX Comparison

KTCC vs SCLX Comparison

Compare KTCC & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTCC
  • SCLX
  • Stock Information
  • Founded
  • KTCC 1969
  • SCLX 2011
  • Country
  • KTCC United States
  • SCLX United States
  • Employees
  • KTCC N/A
  • SCLX N/A
  • Industry
  • KTCC Electrical Products
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KTCC Technology
  • SCLX Health Care
  • Exchange
  • KTCC Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • KTCC 34.0M
  • SCLX 33.9M
  • IPO Year
  • KTCC N/A
  • SCLX N/A
  • Fundamental
  • Price
  • KTCC $2.76
  • SCLX $4.73
  • Analyst Decision
  • KTCC
  • SCLX Strong Buy
  • Analyst Count
  • KTCC 0
  • SCLX 3
  • Target Price
  • KTCC N/A
  • SCLX $367.50
  • AVG Volume (30 Days)
  • KTCC 30.1K
  • SCLX 133.7K
  • Earning Date
  • KTCC 08-12-2025
  • SCLX 08-12-2025
  • Dividend Yield
  • KTCC N/A
  • SCLX N/A
  • EPS Growth
  • KTCC N/A
  • SCLX N/A
  • EPS
  • KTCC N/A
  • SCLX N/A
  • Revenue
  • KTCC $483,941,000.00
  • SCLX $50,710,000.00
  • Revenue This Year
  • KTCC N/A
  • SCLX $107.00
  • Revenue Next Year
  • KTCC N/A
  • SCLX $82.52
  • P/E Ratio
  • KTCC N/A
  • SCLX N/A
  • Revenue Growth
  • KTCC N/A
  • SCLX 7.79
  • 52 Week Low
  • KTCC $2.21
  • SCLX $3.60
  • 52 Week High
  • KTCC $6.14
  • SCLX $78.05
  • Technical
  • Relative Strength Index (RSI)
  • KTCC 44.86
  • SCLX 42.52
  • Support Level
  • KTCC $2.83
  • SCLX $4.56
  • Resistance Level
  • KTCC $3.06
  • SCLX $4.90
  • Average True Range (ATR)
  • KTCC 0.14
  • SCLX 0.58
  • MACD
  • KTCC -0.03
  • SCLX -0.10
  • Stochastic Oscillator
  • KTCC 0.00
  • SCLX 4.73

About KTCC Key Tronic Corporation

Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: